Representatives of the Blood and Tissue Bank, the Institute of Bioengineering of Catalonia, Avinent, Reig Jofré and Biorem, all members of CataloniaBio &  HealthTech, have recently formalized the creation of a working group with the aim of promoting a public-private ecosystem to dynamize and facilitate  the translation of bio-printing solutions to clinical and pharmaceutical  practice in Catalonia, and contribute to the achievement of an integrated, resilient and sustainable healthcare model in the context of the Salut 2030 project.

The initiative for the creation of this working group arose after the impressions exchanged in the  last edition of Lessons Learned, which was dedicated to 3D printing and bio-printing.

The group met on December 9 in the first working session to share and discuss cases of production models of bioimpression in the framework of existing advanced  therapies (ATMPs) in different European countries (Sweden, Germany, and the UK). In these countries, the existence and coexistence of the centralized and decentralized models with different proportions and applications is identified, as well as the specific case of the in-hospital model. The group will now focus on the incorporation of other key actors, the establishment of framework agreements, institutional formalization, and the definition of specific short-term and medium-term goals.

The working group is open to the participation of other institutions, research and/or healthcare centres, companies, etc... interested in translating bio-printing solutions into medical practice. Those interested can contact Caterina Vidal (caterinavidal@biorem.cat) to request their participation in the group.